| [1] |
El-Loly MM. 2022. Colostrum ingredients, its nutritional and health benefits - an overview. |
| [2] |
Buttar HS, Bagwe SM, Bhullar SK, Kaur G. 2017. Health benefits of bovine colostrum in children and adults. In Dairy in Human Health and Disease Across the Lifespan, eds. Watson RR, Collier RJ, Preedy VR. Amsterdam: Elsevier. pp. 3−20. doi: 10.1016/b978-0-12-809868-4.00001-7 |
| [3] |
Mehra R, Singh R, Nayan V, Buttar HS, Kumar N, et al. 2021. Nutritional attributes of bovine colostrum components in human health and disease: a comprehensive review. |
| [4] |
Gomes RDS, Anaya K, Galdino ABS, Oliveira JPF, Gama MAS, et al. 2021. Bovine colostrum: a source of bioactive compounds for prevention and treatment of gastrointestinal disorders. |
| [5] |
McGrath BA, Fox PF, McSweeney PLH, Kelly AL. 2016. Composition and properties of bovine colostrum: a review. |
| [6] |
Poonia A, Shiva. 2022. Bioactive compounds, nutritional profile and health benefits of colostrum: a review. |
| [7] |
Sacerdote P, Mussano F, Franchi S, Panerai AE, Bussolati G, et al. 2013. Biological components in a standardized derivative of bovine colostrum. |
| [8] |
Ghosh S, Iacucci M. 2021. Diverse immune effects of bovine colostrum and benefits in human health and disease. |
| [9] |
Korhonen HJ. 2009. Bioactive components in bovine milk. In Bioactive Components in Milk and Dairy Products, eds. Park YW. Danvers, MA: Blackwell Publishing. pp. 13−42. doi: 10.1002/9780813821504.ch2 |
| [10] |
Stelwagen K, Carpenter E, Haigh B, Hodgkinson A, Wheeler TT. 2009. Immune components of bovine colostrum and milk. |
| [11] |
Ahmann J, Steinhoff-Wagner J, Büscher W. 2021. Determining immunoglobulin content of bovine colostrum and factors affecting the outcome: a review. |
| [12] |
Singh VK. 1971. The IgG immunoglobulins of bovine colostrum and milk: selected biochemical and antimicrobial properties. PhD Dissertation. The Ohio State University, United States |
| [13] |
Atkinson DJ, von Keyserlingk MAG, Weary DM. 2017. Benchmarking passive transfer of immunity and growth in dairy calves. |
| [14] |
Feeney S, Morrin S, Joshi L, Hickey R. 2018. The role of immunoglobulins from bovine colostrum and milk in human health promotion. In Novel Proteins for Food, Pharmaceuticals and Agriculture: Sources, Applications and Advances, ed. Hayes M. USA: John Wiley & Sons. pp. 291−314. doi: 10.1002/9781119385332.ch16 |
| [15] |
Tsioulpas A, Grandison AS, Lewis MJ. 2007. Changes in physical properties of bovine milk from the colostrum period to early lactation. |
| [16] |
Mesmin C, Fenaille F, Becher F, Tabet JC, Ezan E. 2011. Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry. |
| [17] |
Jelinek DF, Li JT. 2014. Immunoglobulin structure and function. In Middleton's Allergy, ed. Adkinson NF, Bochner BS, Burks AW, Busse WW, Holgate ST, et al. 8th Edition. London: W.B. Saunders. pp. 30−44. pp. doi: 10.1016/B978-0-323-08593-9.00004-8 |
| [18] |
Ereño-Orbea J, Sicard T, Cui H, Carson J, Hermans P, et al. 2018. Structural basis of enhanced crystallizability induced by a molecular chaperone for antibody antigen-binding fragments. |
| [19] |
Ulfman LH, Leusen JHW, Savelkoul HFJ, Warner JO, van Neerven RJ. 2018. Effects of bovine immunoglobulins on immune function, allergy, and infection. |
| [20] |
Drikic M, Windeyer C, Olsen S, Fu Y, Doepel L, et al. 2018. Determining the IgG concentrations in bovine colostrum and calf sera with a novel enzymatic assay. |
| [21] |
Sandomirsky BP, Galchenko SE, Galchenko KS. 2003. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization. Cryo Letters 24:275−80 |
| [22] |
Lu RR, Xu SY, Wang Z, Yang RJ. 2007. Isolation of lactoferrin from bovine colostrum by ultrafiltration coupled with strong cation exchange chromatography on a production scale. |
| [23] |
Csapó J, Lóki K, Béri B, Süli Á, Varga-Visi É, et al. 2011. Colostrum and milk of current and rare cattle breeds: protein content and amino acid composition. Acta Universitatis Sapientiae: Alimentaria 4:18−27 |
| [24] |
Jiang R, Du X, Lönnerdal B. 2014. Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. |
| [25] |
Arslan A, Kaplan M, Duman H, Bayraktar A, Ertürk M, et al. 2021. Bovine colostrum and its potential for human health and nutrition. |
| [26] |
Mehra R, Garhwal R, Sangwan K, Guiné RPF, Lemos ET, et al. 2022. Insights into the research trends on bovine colostrum: beneficial health perspectives with special reference to manufacturing of functional foods and feed supplements. |
| [27] |
Alnadari F, Abdin M, Ennab W, Mohedein A, Nasiru MM. 2020. Metabolism of anthocyanins and modulation of gut microbiome in inflammatory bowel disease. |
| [28] |
Gauthier SF, Pouliot Y, Maubois JL. 2006. Growth factors from bovine milk and colostrum: composition, extraction and biological activities. |
| [29] |
Laviola L, Natalicchio A, Giorgino F. 2007. The IGF-I signaling pathway. |
| [30] |
Georgiev IP. 2008. Differences in chemical composition between cow colostrum and milk. Bulgarian Journal of Veterinary Medicine 11:3−12 |
| [31] |
Playford RJ, MacDonald CE, Johnson WS. 2000. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. |
| [32] |
Ragab S, El-Kholy A. 2007. Antioxidant properties of bovine colostrum and its main bioactive constituents of lactoferrin and lactoperoxidase. |
| [33] |
Kussendrager KD, van Hooijdonk AC. 2000. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. |
| [34] |
Panwar H. 2014. Biologically active components of human and bovine milk as potent antimicrobial agents. Journal of Innovative Biology 1:97−104 |
| [35] |
Jolanta Kl, Aneta B, Zygmunt Lc, Joanna B. 2012. Selected factors determining the content of lactoferrin, lysozyme and immunoglobulins G in bovine milk. In A Search for Antibacterial Agents, ed. Varaprasad B. Rijeka: IntechOpen. pp. 107-24. doi: 10.5772/46047 |
| [36] |
Stepaniak L. 2002. Isolation and partial characterization of catalytic antibodies with oligonuclease activity from bovine colostrum. |
| [37] |
Magboul AAA, Larsen LB, McSweeney PLH, Kelly AL. 2001. Cysteine protease activity in bovine milk. |
| [38] |
Deeth HC. 2006. Lipoprotein lipase and lipolysis in milk. |
| [39] |
Calamari L, Gobbi L, Russo F, Piccioli Cappelli F. 2015. Pattern of γ-glutamyl transferase activity in cow milk throughout lactation and relationships with metabolic conditions and milk composition. |
| [40] |
Hagiwara K, Kataoka S, Yamanaka H, Kirisawa R, Iwai H. 2000. Detection of cytokines in bovine colostrum. |
| [41] |
Yalçıntaş YM, Duman H, Rocha JM, Bartkiene E, Karav S, et al. 2024. Role of bovine colostrum against various diseases. |
| [42] |
Miranda C, Igrejas G, Poeta P. 2023. Bovine colostrum: human and animal health benefits or route transmission of antibiotic resistance—one health perspective. |
| [43] |
Goi A, De Marchi M, Costa A. 2023. Minerals and essential amino acids of bovine colostrum: Phenotypic variability and predictive ability of mid- and near-infrared spectroscopy. |
| [44] |
Williams M. 2005. Dietary supplements and sports performance: amino acids. |
| [45] |
Zándoki R, Csapó J, Csapó-Kiss Z, Tábori I, Domokos Z, et al. 2006. Change of amino acid profile in Charolais cows' colostrum and transient milk during the first week post partum. |
| [46] |
Kehoe SI, Jayarao BM, Heinrichs AJ. 2007. A survey of bovine colostrum composition and colostrum management practices on Pennsylvania dairy farms. |
| [47] |
Dande N, Nande P. 2020. Nutritional composition of bovine colostrum: palatability evaluation of food products prepared using bovine colostrum. International Journal of Nutrition, Pharmacology, Neurological Diseases 10:8−13 |
| [48] |
MacGibbon AKH, Taylor MW. 2013. Composition and structure of bovine milk lipids. In Advanced Dairy Chemistry, Volume 2, Lipids, eds. Fox PF, McSweeney PLH. Boston, MA: Springer. doi: 10.1007/0-387-28813-9_1 |
| [49] |
Sats A, Yurchenko S, Kaart T, Tatar V, Lutter L, et al. 2022. Bovine colostrum: Postpartum changes in fat globule size distribution and fatty acid profile. |
| [50] |
Alnadari F, Almakas A, Nasiru MM, Abdalmegeed D, Aleem MT, et al. 2022. Immobilization and recyclability of β-glucosidase from Thermatoga maritima on biopolymer-coated magnetic nanoparticles. In Animal Health Perspectives eds. Abbas RZ, Khan A, Liu P, Saleemi MK. Vol. 2. Faisalabad, Pakistan: Unique Scientific Publishers. pp: 237−43. doi: 10.47278/book.ahp/2022.65 |
| [51] |
Alnadari F, Xue Y, Almakas A, Mohedein A, Samie A, et al. 2021. Large batch production of Galactooligosaccharides using β-glucosidase immobilized on chitosan-functionalized magnetic nanoparticle. |
| [52] |
Alnadari F, Xue Y, Zhou L, Hamed YS, Taha M, et al. 2020. Immobilization of β-glucosidase from thermatoga maritima on chitin-functionalized magnetic nanoparticle via a novel thermostable chitin-binding domain. |
| [53] |
Alnadari F, Xue Y, Alsubhi NH, Alamoudi SA, Alwabli AS, et al. 2022. Reusability of immobilized β-glucosidase on sodium alginate-coated magnetic nanoparticles and high productivity applications. |